Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy
Purpose: The study aimed to establish a prognostic prediction model and an artificial neural network (ANN) model to determine who will benefit from transarterial chemoembolization (TACE) monotherapy for patients with hepatocellular carcinoma (HCC) invading portal vein. Methods: Treatment-naïve patie...
Main Authors: | Lei Zhang, BinYan Zhong, Bo Hu, Wei Li, Peng Huang, Shen Zhang, JinJin Song, JianSong Ji, CaiFang Ni |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2020-12-01
|
Series: | Journal of Interventional Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2096360220300491 |
Similar Items
-
Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
by: Won-Gyom Choe, et al.
Published: (2018-01-01) -
Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
by: Yashwant Patidar, et al.
Published: (2021-04-01) -
Chemoembolization Plus Radiotherapy Versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis
by: Hee Ho Chu, et al.
Published: (2020-04-01) -
Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
by: Jung Min Lee, et al.
Published: (2016-03-01) -
Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
by: Yanyan Cao, et al.
Published: (2021-08-01)